BOSTON SCIENTIFIC CORP
Public company- Headquarters
- MARLBOROUGH, Massachusetts
- Ticker
- BSX
- CIK
- 0000885725
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
| Notice date | Workers affected | Cumulative |
|---|---|---|
| Oct 23, 2024 | 30 | 30 |
| Apr 15, 2025 | 63 | 93 |
| Jun 10, 2025 | 23 | 116 |
Leadership
| Role and person | Since | Change |
|---|---|---|
| COOJoe Fitzgerald | Oct 7, 2026 | Appointed |
| Senior Vice President, Global Finance Controller and Finance TransformationEmily Woodworth (Collins) | Oct 7, 2026 | Appointed |
| Chief Accounting OfficerEmily Woodworth (Collins) | Oct 7, 2026 | Departed |
| Senior Vice President, Global Accounting Controller and Chief Accounting OfficerMark Bickel | Oct 7, 2026 | Appointed |
| Executive Vice President and Group President, MedSurg and Asia PacificArthur C. Butcher | Sep 23, 2026 | Departed |
Related companies
Same industry and state, with recent events.
- FRACTYL HEALTH, INC.
Class III director appointed: Michael Wartell
- LEMAITRE VASCULAR INC
President departs: David B. Roberts
- INSULET CORP
member of the Board of Directors departs: Timothy J. Scannell
- HAEMONETICS CORP
Plant closure: CA
- Executive appointment
COO appointed: Joe Fitzgerald
Joe Fitzgerald was named Executive Vice President and Chief Operating Officer of BOSTON SCIENTIFIC CORP, effective January 1, 2027. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Oct 7, 2026Role: Executive Vice President and Chief Operating Officer
- Executive appointment
Senior Vice President, Global Finance Controller and Finance Transformation appointed: Emily Woodworth (Collins)
Emily Woodworth (Collins) was named Senior Vice President, Global Finance Controller and Finance Transformation of BOSTON SCIENTIFIC CORP, effective March 1, 2027. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Oct 7, 2026Role: Senior Vice President, Global Finance Controller and Finance Transformation
- Executive departure
Chief Accounting Officer departs: Emily Woodworth (Collins)
Emily Woodworth (Collins), Chief Accounting Officer of BOSTON SCIENTIFIC CORP, departs the role, effective March 1, 2027. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Oct 7, 2026Role: Chief Accounting Officer
- Executive appointment
Senior Vice President, Global Accounting Controller and Chief Accounting Officer appointed: Mark Bickel
Mark Bickel was named Senior Vice President, Global Accounting Controller and Chief Accounting Officer of BOSTON SCIENTIFIC CORP, effective March 1, 2027. Mark Bickel succeeds Emily Woodworth (Collins). The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Oct 7, 2026Role: Senior Vice President, Global Accounting Controller and Chief Accounting Officer
- Executive departure
Executive Vice President and Group President, MedSurg and Asia Pacific departs: Arthur C. Butcher
Arthur C. Butcher, Executive Vice President and Group President, MedSurg and Asia Pacific of BOSTON SCIENTIFIC CORP, retires the role, effective January 1, 2027. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Sep 23, 2026Role: Executive Vice President and Group President, MedSurg and Asia Pacific
Last verified Nov 8, 2026